Avexa Limited and Progen Pharmaceuticals Limited Merger Update

January 5, 2009 |

1 min read

MELBOURNE, Australia--(BUSINESS WIRE)--Biotechnology companies Avexa Limited (ASX:AVX) and Progen Pharmaceuticals Limited (ASX:PGL) (NASDAQ:PGLA) announced an update to shareholders regarding their proposed merger.

Mergers & acquisitions Asia Australia

MORE ON THIS TOPIC

3d fatty liver disease isolated on pink background. 3d illustration render

MASH

Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech

February 11, 2026

·

2 min read

·

Tristan Manalac

3d illustration of a robotic hand holding a medical capsule on blue backdrop with space for text and images. Concept of automated medical treatment.

Artificial intelligence

AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery

February 11, 2026

·

8 min read

·

Annalee Armstrong

Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.

Obesity

Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study

February 10, 2026

·

1 min read

·

Tristan Manalac

Creativity and new ideas in business. Art collage.

Mergers & acquisitions

Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune

February 9, 2026

·

2 min read

·

Dan Samorodnitsky